Novavax ((NVAX)) shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement with Sanofi (SNY).
The agreement involves co-development of Covid/flu vaccine combinations for both companies. Sanofi will be licensed to co-commercialize the vaccine worldwide.
As part of the agreement, Sanofi will take a minority equity position in Novavax. It will…

#nvax#sanofi#novavax#maryland